Seigo Izumo, MD

Senior Vice President, Cardiovascular Therapeutics

Seigo Izumo, MD joined Gilead as Senior Vice President, Cardiovascular Therapeutics in September 2008. In this role, Dr. Izumo oversees Gilead’s growing cardiovascular business unit. Dr. Izumo most recently served as Vice President & Global Head of Cardiovascular Research at Novartis Institutes for BioMedical Research. Prior to joining Novartis in July 2003, he served as Professor of Medicine at Harvard Medical School in Boston and at Harvard-MIT Division of Health Sciences and Technology. In addition to his academic position at Harvard, Dr. Izumo was Director of Cardiovascular Research and Physician, Department of Medicine, Beth Israel Deaconess Medical Center, Boston and Director of the CardioGenomics Program, a National, Heart Lung and Blood Institute-sponsored initiative. Previously, he was Chief of the Cardiology Division and Professor of Internal Medicine and Biological Chemistry, University of Michigan Medical School in Ann Arbor.

Dr. Izumo received his undergraduate and medical degrees from the University of Tokyo.